{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:02:25Z","timestamp":1761490945348},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To develop a population pharmacokinetic model for IV phenobarbital in neonates following cardiac surgery and perform simulations to identify optimal dosing regimens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective single-center pharmacokinetic study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Cardiac ICU at Children\u2019s Hospital of Philadelphia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Consecutive neonates who received greater than or equal to one dose of IV phenobarbital and had greater than or equal to one phenobarbital concentration drawn per standard of care from June 15, 2012, to October 15, 2018.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>A population pharmacokinetic model was developed using nonlinear mixed-effects modeling. Simulations were performed using the final model variables. Optimal phenobarbital loading doses were determined based on attainment of peak and maintenance concentrations between 20 and 40 mg\/L. A total of 37 neonates contributed 159 pharmacokinetic samples. The median (range) weight, postmenstrual age, and postnatal age were 3.2 kg (1.3\u20133.8), 39 2\/7 weeks (28 2\/7 to 42 6\/7), and 5 days (0\u201326 d), respectively. Twelve patients (32%) were on extracorporeal membrane oxygenation. An one-compartment model best described the data. The final population pharmacokinetic model included (1) weight and postnatal age for clearance and (2) weight, extracorporeal membrane oxygenation, and albumin for volume of distribution. In neonates not on extracorporeal membrane oxygenation, loading doses of 30 and 20 mg\/kg reached goal concentration with albumin values less than or equal to 3 and 3.5 mg\/dL, respectively. Loading doses of 30 mg\/kg reached goal concentration on extracorporeal membrane oxygenation regardless of albumin values. Maintenance doses of 4\u20135 mg\/kg\/d reached goal concentration in all neonates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In neonates following cardiac surgery, phenobarbital clearance increased with postnatal age. Volume of distribution increased with extracorporeal membrane oxygenation and lower albumin values. Loading doses of 30 mg\/kg on extracorporeal membrane oxygenation and 20\u201330 mg\/kg without extracorporeal membrane oxygenation were needed to reach goal concentration based on simulations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000002341","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T03:28:39Z","timestamp":1584070119000},"page":"e557-e565","source":"Crossref","is-referenced-by-count":7,"title":["Population Pharmacokinetics of IV Phenobarbital in Neonates After Congenital Heart Surgery"],"prefix":"10.1097","volume":"21","author":[{"given":"C\u00e9line","family":"Thibault","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."},{"name":"Center for Clinical Pharmacology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shavonne L.","family":"Massey","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Pediatrics, Children\u2019s Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Y.","family":"Naim","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Abend","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Pediatrics, Children\u2019s Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athena F.","family":"Zuppa","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."},{"name":"Center for Clinical Pharmacology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,3,13]]},"reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jtcvs.2015.03.045","article-title":"Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery.","volume":"150","author":"Naim","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jtcvs.2013.04.002","article-title":"Postoperative electroencephalographic seizures are associated with deficits in executive function and social behaviors at 4 years of age following cardiac surgery in infancy.","volume":"146","author":"Gaynor","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1056\/NEJM199310073291501","article-title":"A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary bypass in infant heart surgery.","volume":"329","author":"Newburger","year":"1993","journal-title":"N Engl J Med"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0013-4694(96)95079-8","article-title":"Perioperative electroencephalographic seizures in infants undergoing repair of complex congenital cardiac defects.","volume":"102","author":"Helmers","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCULATIONAHA.111.026963","article-title":"Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure: neuropsychological assessment and structural brain imaging.","volume":"124","author":"Bellinger","year":"2011","journal-title":"Circulation"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0883073812470734","article-title":"Pharmacological treatment of neonatal seizures: A systematic review.","volume":"28","author":"Slaughter","year":"2013","journal-title":"J Child Neurol"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1573397111666151026223914","article-title":"Clinical pharmacology of phenobarbital in neonates: Effects, metabolism and pharmacokinetics.","volume":"12","author":"Pacifici","year":"2016","journal-title":"Curr Pediatr Rev"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2710.2010.01220.x","article-title":"Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: An update.","volume":"36","author":"Yukawa","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/fcp.12042","article-title":"Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach.","volume":"28","author":"Marsot","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/PCC.0b013e31825bbbc2","article-title":"Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia.","volume":"14","author":"Shellhaas","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1528-1167.2011.02978.x","article-title":"Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: A pharmacokinetic study during whole body hypothermia.","volume":"52","author":"Filippi","year":"2011","journal-title":"Epilepsia"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jcpt.12632","article-title":"Estimation of initial phenobarbital dosing in term neonates with moderate-to-severe hypoxic ischaemic encephalopathy following perinatal asphyxia.","volume":"43","author":"\u0160\u00edma","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.ejps.2017.05.026","article-title":"Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation.","volume":"109S","author":"V\u00f6ller","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/0267659118766444","article-title":"Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation.","volume":"33","author":"Pokorn\u00e1","year":"2018","journal-title":"Perfusion"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/archdischild-2011-300538","article-title":"Effects of cytochrome P450 (CYP)2C19 polymorphisms on pharmacokinetics of phenobarbital in neonates and infants with seizures.","volume":"97","author":"Lee","year":"2012","journal-title":"Arch Dis Child"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/epi.14447","article-title":"Phenobarbital population pharmacokinetics across the pediatric age spectrum.","volume":"59","author":"Moffett","year":"2018","journal-title":"Epilepsia"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0928-0987(00)00145-7","article-title":"Clinical pharmacokinetics of phenobarbital in neonates.","volume":"12","author":"Touw","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40262-012-0004-y","article-title":"Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: A thermopharmacological approach.","volume":"51","author":"van den Broek","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jtcvs.2011.06.021","article-title":"Congenital heart surgery in infants: effects of acute kidney injury on outcomes.","volume":"143","author":"Blinder","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.100.5.526","article-title":"Developmental and neurological status of children at 4 years of age after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass.","volume":"100","author":"Bellinger","year":"1999","journal-title":"Circulation"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1023\/A:1018828709196","article-title":"The effect of collinearity on parameter estimates in nonlinear mixed effect models.","volume":"16","author":"Bonate","year":"1999","journal-title":"Pharm Res"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/jps.23574","article-title":"A pharmacokinetic standard for babies and adults.","volume":"102","author":"Holford","year":"2013","journal-title":"J Pharm Sci"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00543794","article-title":"Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.","volume":"25","author":"D\u00f8ssing","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"R25-20230823","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1542\/peds.83.5.674","article-title":"Rapid sequential phenobarbital treatment of neonatal seizures.","volume":"83","author":"Gilman","year":"1989","journal-title":"Pediatrics"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-3476(59)80084-6","article-title":"The blood volume of infants. I. The full-term infant in the first year of life.","volume":"55","author":"Sisson","year":"1959","journal-title":"J Pediatr"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"e0045","DOI":"10.1097\/CCE.0000000000000045","article-title":"Patterns of medication exposure in children on extracorporeal membrane oxygenation: A step in prioritizing future pharmacologic studies.","volume":"1","author":"Thibault","year":"2019","journal-title":"Critical Care Explorations"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.12851216","article-title":"Biomarkers for diagnosis and prognosis of AKI in children: One size does not fit all.","volume":"12","author":"Greenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-20230823","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1542\/pir.20.11.376","article-title":"Evaluation of liver disease in the pediatric patient.","volume":"20","author":"D\u2019Agata","year":"1999","journal-title":"Pediatr Rev"},{"key":"R30-20230823","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1378\/chest.11-1396","article-title":"Introduction to drug pharmacokinetics in the critically ill patient.","volume":"141","author":"Smith","year":"2012","journal-title":"Chest"},{"key":"R31-20230823","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1600-0773.2001.088001003.x","article-title":"Neonatal hepatic drug elimination.","volume":"88","author":"Gow","year":"2001","journal-title":"Pharmacol Toxicol"},{"key":"R32-20230823","first-page":"352","article-title":"Evaluation of the effects of extracorporeal membrane oxygenation on antiepileptic drug serum concentrations in pediatric patients.","volume":"22","author":"Dillman","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R33-20230823","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00134-007-0606-2","article-title":"Potential drug sequestration during extracorporeal membrane oxygenation: Results from an ex vivo experiment.","volume":"33","author":"Mehta","year":"2007","journal-title":"Intensive Care Med"},{"key":"R34-20230823","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40262-017-0549-x","article-title":"A physiologically based pharmacokinetic perspective on the clinical utility of albumin-based dose adjustments in critically ill patients.","volume":"57","author":"T\u2019jollyn","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"R35-20230823","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003088-197601020-00001","article-title":"Clincial pharmacokinetics in neonates.","volume":"1","author":"Morselli","year":"1976","journal-title":"Clin Pharmacokinet"},{"key":"R36-20230823","first-page":"264","article-title":"Phenytoin and phenobarbital protein binding alterations in a uremic burn patient.","volume":"21","author":"Pugh","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"key":"R37-20230823","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1177\/0883073816664670","article-title":"Standardized treatment of neonatal status epilepticus improves outcome.","volume":"31","author":"Harris","year":"2016","journal-title":"J Child Neurol"},{"key":"R38-20230823","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00003246-199502000-00028","article-title":"Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus.","volume":"23","author":"Mirski","year":"1995","journal-title":"Crit Care Med"},{"key":"R39-20230823","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pediatrneurol.2005.06.014","article-title":"Very-high-dose phenobarbital for childhood refractory status epilepticus.","volume":"34","author":"Lee","year":"2006","journal-title":"Pediatr Neurol"},{"key":"R40-20230823","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2013best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:45:52Z","timestamp":1692837952000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,13]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000002341","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,13]]}}}